Information Americas, NEW YORK, NY, Tues. July 22, 2025: In Brazil’s Atlantic forests, a nondescript shrub lengthy dismissed as botanical background noise might maintain the important thing to the following international CBD revolution—and a extra equitable future in well being and agriculture.
Scientists have confirmed that Trema micrantha, a fast-growing native plant, produces CBD with out THC, the psychoactive compound that retains hashish tightly regulated worldwide. The implications stretch far past pharmacology: this might reshape how nations within the World South enter and lead within the $47 billion cannabinoid economic system – with out counting on the Western-dominated hemp trade or overcoming steep authorized hurdles tied to hashish.
“That is greater than only a scientific discovery. It’s a geopolitical second,” says Dr. Rodrigo Moura Neto of the Federal College of Rio de Janeiro. “For international locations like Brazil, it’s an opportunity to be producers, not simply shoppers.”
Not like hemp, which requires licenses, fencing, and THC testing, Trema micrantha grows like a weed—actually. It’s unregulated, fast-reproducing, and able to thriving in tropical climates the place hemp struggles. The shrub additionally sidesteps cultural stigma and authorized grey zones surrounding marijuana, providing a culturally impartial, legally clear pathway to CBD therapeutics.
As Brazilian researchers safe funding and navigate course of patents, they’re overtly inviting the scientific group to discover its potential—an uncommon stance in a fiercely aggressive pharmaceutical house. “Open science can degree the enjoying area,” Moura Neto provides, “particularly for Latin America and the Caribbean.”
The invention additionally indicators a shift towards bio-sovereignty, giving resource-rich however capital-starved nations a strategy to management their very own medical provide chains, cut back import prices, and develop entry to plant-based medication for circumstances like epilepsy and PTSD.
Nonetheless, challenges stay: cannabinoid yield per acre is decrease than engineered hemp, and medical trials will take years. But Trema micrantha stands as a vivid reminder: typically, the way forward for medication grows unnoticed alongside the roadside—till science decides to look once more.
Keep forward of the curve with NextBusiness 24. Discover extra tales, subscribe to our e-newsletter, and be a part of our rising group at nextbusiness24.com
